Concepedia

Anilkumar G. Nair

AG

Statistics

Publications

16

Citations

421

H-Index

13

Active since

1996

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

WuXi AppTec (China)

United States Military Academy

Anilkumar G. Nair is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in pharmacology, drug discovery, and medicinal chemistry.

Publications per year

1996–2023

16

Publications

16

Orally Bioavailable Macrocyclic Peptide That Inhibits Binding of PCSK9 to the Low Density Lipoprotein Receptor

Douglas G. Johns, Louis‐Charles Campeau, Puja Banka et al. · Circulation · 2023 · 141 citations · Full text

, , +17

Discovery of Ruzasvir (MK-8408): A Potent, Pan-Genotype HCV NS5A Inhibitor with Optimized Activity against Common Resistance-Associated Polymorphisms

Ling Tong, Wensheng Yu, Lei Chen et al. · Journal of Medicinal Chemistry · 2016 · 47 citations · Full text

, , +17

Discovery of silyl proline containing HCV NS5A inhibitors with pan-genotype activity: SAR development

Anilkumar G. Nair, Qingbei Zeng, Oleg Selyutin et al. · Bioorganic & Medicinal Chemistry Letters · 2016 · 27 citations · Full text

, , +15

Diels-Alder Reactions of a 6-Arenyl Fulvene Participating both as Diene and Dienophile

Vijay Nair, Anilkumar G. Nair, K. V. Radhakrishnan et al. · Synlett · 1997 · 25 citations

, , +7

IV. Discovery of CXCR3 antagonists substituted with heterocycles as amide surrogates: Improved PK, hERG and metabolic profiles

Anilkumar G. Nair, Michael Wong, Youheng Shu et al. · Bioorganic & Medicinal Chemistry Letters · 2014 · 19 citations · Full text

, , +14

1–5 of 16